NOTCH1 and lip and oral cavity carcinoma: If NOTCH1 biomarkers are accurately assessed for diverse clinical traits, including immunological responses and patterns of therapeutic reaction, there can be advances in personalized treatments for oral cancer as part of precision medicine [7,8].